menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    CenExel Supports Metsera’s Ph 2 Success Of MET-097 In Obesity & Diseases

    ACCESSWIRE

    Metsera to Present at TD Cowen’s Health Care Conference

    GLOBENEWSWIRE

    Metsera Closes IPO & Full Exercise of Underwriters’ Option

    GLOBENEWSWIRE

    Metsera hits $2.7 bln valuation as shares surge 42% in Nasdaq debut

    REUTERS

    Metsera targets up to $1.78 billion valuation in US IPO

    REUTERS

    Obesity biotech Metsera files for a swift IPO

    FIERCE BIOTECH

    Weight-loss drug developer Metsera reveals wider loss in IPO

    REUTERS

    Metsera Touts ‘Powerful’ Weight Loss Results

    BIOSPACE

    Altasciences Supports Metsera in Obesity Clinical Trials

    BUSINESSWIRE

    Metsera Raises Another $215M for Long-Acting GLP-1

    BIOSPACE

    Metsera Raises $215M for Long-Acting GLP-1 Obesity Treatment

    BIOSPACE

    Amneal And Metsera Partner On Next-Gen Obesity Medicines

    BUSINESSWIRE

    Metsera GLP-1 data slice reveals 7.5% weight loss at 36 days

    FIERCE BIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.